1. Home
  2. ALOT vs FATE Comparison

ALOT vs FATE Comparison

Compare ALOT & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AstroNova Inc.

ALOT

AstroNova Inc.

N/A

Current Price

$15.17

Market Cap

109.5M

Sector

Technology

ML Signal

N/A

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

N/A

Current Price

$2.22

Market Cap

125.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALOT
FATE
Founded
1969
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
109.5M
125.6M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
ALOT
FATE
Price
$15.17
$2.22
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$4.10
AVG Volume (30 Days)
45.4K
4.6M
Earning Date
04-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
83.94
29.88
EPS
N/A
N/A
Revenue
$150,515,000.00
$6,646,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.96
$0.91
52 Week High
$16.07
$2.88

Technical Indicators

Market Signals
Indicator
ALOT
FATE
Relative Strength Index (RSI) 67.92 52.21
Support Level $13.44 $1.00
Resistance Level N/A N/A
Average True Range (ATR) 0.60 0.25
MACD -0.02 -0.01
Stochastic Oscillator 72.76 46.12

Price Performance

Historical Comparison
ALOT
FATE

About ALOT AstroNova Inc.

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Aerospace. It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: